Dr Tina Peers
The Menopause Consultancy & MCAS Expert
Long Covid patients symptoms, past medical histories and response to treatments.
Dr Bruce Patterson
MD, CEO, IncellDx Inc.
Bruce K. Patterson, MD is a leading researcher on the effects of viral pathogens on the human immune system. His pioneering technologies and findings have contributed to advances in detection, prognosis and treatment of patients infected with HIV, HPV and cervical cancer,COVID-19 and other disease.
Using PCR-driven in situ hybridization and flow cytometry to detect viral DNA and RNA within infected cells, Dr. Patterson and colleagues demonstrated that HIV entered and multiplied in the host cells in a stealthy fashion that eluded discovery. This groundbreaking work was published in the peer-reviewed journal Science. He also developed a new method to investigate the effect of antiretroviral therapy within the infected host cell and published this discovery in the peer-reviewed journal Lancet.
Dr. Patterson continues his work on HIV-1pathogenesis and reservoirs at Stanford University School of Medicine, where he previously served as Medical Director of Diagnostic Virology at Stanford University Hospitals and Clinics, director of clinical virology, and co-director of the AIDS Research Center.
Dr. Patterson received his undergraduate degree in microbiology from the University of Michigan and his MD from Northwestern, where he later served as Chief Resident of Pathologyat Northwestern Memorial Hospital. He has authored more than 150 manuscripts and book chapters.
Dr. Patterson serves as CEO of InCellDx, where he is developing a new paradigm for predicting, identifying and treating long COVID-19 and other viral pathogens that impair the immune system’s ability to function effectively.
Dr. Lawrence B. Afrin
Consultant Oncologist and Haematologist
Mast Cell Activation Disease: Current Concepts
Dr. Afrin trained and practiced as an internist and hematologist/oncologist at the Medical University of South Carolina 1984-2014 and further practiced at the University of Minnesota 2014-2017, coming to focus his interests in mast cell disease since the mid-’00s. Since 2017, he has been developing an institute in New York for advancing care, research, and education in this area. He has published highly accessed articles about mast cell activation syndrome and a popular book in the field.
Susanne Schmidt, PhD
University of Bonn
Long Covid Blood Analysis Results from a UK Cohort of Patients
Susanne V. Schmidt studied biology at the University of Cologne. She graduated in 2009 investigating the modulation of dendritic cell function by tumor cells at the Institute for Virology in Cologne. In 2010 Susanne Schmidt joined as a PostDoc the Genomics & Immunoregulatory Group at the LIMES Institute in Bonn. Since 2017 Susanne is a member of the Eicke Latz Group. She is a certified clinical monitor and holds educational certificates in the fields of Genomic Data Science, Machine Learning and Psychology. Her current research is focused on the decipherment of epigenetic and transcriptional programming of peripheral monocytes during SARS-CoV-2 infection, identification of biomarkers for patients at risk to develop hyperinflammatory immune reactions, monitoring of epigenetic alterations in brain tumors and the role of TAM receptors in the regulation of myeloid cell programming.
Ashok Gupta, MA(Cantab), MSc.
Clinical Director of the Gupta Program
Neuroplasticity "Brain Retraining" Approaches for Long Covid
Ashok has spent 20 years studying and treating chronic illnesses such as ME/CFS & Fibromyalgia. He has recently had a randomized controlled trial published showing that the Gupta Program was effective at treating Fibromyalgia compared to a control, in the Journal of Clinical Medicine. He is currently using the same "Neuroplasticity Brain Retraining" techniques to treat Long Haul Covid, with anecdotal positive outcomes to share. www.guptaprogram.com
Prof. Héctor Carvallo
Prof. Of Internal Medicine Universidad Abierta Interamericana
Ivermectin in Long Covid
Professor Hector Carvallo has spent the last 35 years working for Medical Education, reaching the status of Professor of Internal Medicine. He is currently working on new devices to defeat SARs COV 2, and has been appointed as Editor in Chief of the newly released OAJ Research & Applied Medicine.
Dr Mobeen Syed
CEO and Founder of DrBeen Corp
Consensus Protocol for Treating Long Covid
Mobeen Syed M.D., M.S., graduated from King Edward Medical University in 1994. After practicing clinical medicine for a few years, he continued his studies in Computer Science with the goal of merging innovative technologies and healthcare. Dr. Mobeen’s dedication for teaching began at Horizon Medical Institute.
His interests and knowledge enabled medics to learn in junction with new technologies.Dr. Mobeen’s unique skillset as a physician and software engineer enabled him to innovate several products, including a portable 3D ultrasound system designed by MediTeQ RI. His experience as a high tech executive includes time at Staples, Kohl’s, Rue Lala, Gemvara, TJX, and most recently e-commerce giant, PayPal.
Dr. Mobeen’s dedication to innovative and pioneering medical education has been a mainstay in his life. At DrBeen Corp, he strives to create a managed marketplace for medical providers that enables them to learn medicine in conjunction with new technologies.
Dr. Danilo Buonsenso
Immune Profiling of Children with Long Haul symptoms
Danilo Buonsenso is working at Department of Pediatrics, Catholic University of the Sacred Heart, A. Gemelli Hospital, Rome, Italy. Danilo Buonsenso’s international experience includes various programs, contributions and participation in different countries for diverse fields of study. Danilo Buonsenso Research interests reflect in wide range of publications in various national and international journals
CEO Peoplewith App
How does Long Covid present across PeopleWith diverse health profiles?
PeopleWith empowers anyone challenged with symptoms to capture their health presentation and progression to share with their healthcare providers in a medically acceptable interpretable format. Long Covid has been tracked for 6 months across diverse health profiles. Todays presentation is a reflection of the data to include patient profiles affected, the variance of symptom presentations across the profiles and health interventions presented.
Patient and Long Haul Advocate, Film Maker and Activist
Experiences with Long Haul and Investigations into Various Treatment Options
After becoming unwell with Covid in March 2020 (whilst training for a 2hr50 time in April’s doomed London Marathon), Gez has put his efforts into becoming an patient advocate for the Long Covid condition, interviewing some of the world’s leading clinicians and conducting over a dozen patient led studies documented on his youtube channel, which currently has almost 4 million views.
Gez will talk about his experience with Long Covid, what drove him to his deep dive into attempting to understand the condition, what he’s learnt in the process and what the most valuable lessons are for and from the thousands of people who’ve taken part in his studies.
Nutritional Therapist invivo healthcare
Gut testing results in our series of LC patients
Debbie Cotton MA, BHSc, AdDipNat is an integrative psychotherapist, naturopath and herbalist and is currently the Head of Clinical Education at Invivo Healthcare, a company who specialises in the human microbiome. She is a busy clinician and lecturer in the health sciences for over 15 years both in Australia and the UK. Her work centres on what it is to be human, and how ecosystem relationships (human, natural world and microbial) shape who we are and our health and wellbeing.
Emma Beswick MBA, BA (Hons), NT(Dip)
Nutrigenomics as an enabler of personalised support for Long COVID patients.
Emma is the CEO of Lifecode Gx®, the leading nutrigenomics testing, analysis and training company. Emma’s focus is on common genetic variants (SNPs) whose potential impacts can be adjusted and compensated through personalised nutrition and lifestyle. Although we can’t change our genetic code, we can apply the science of nutrigenomics, to get to the root of the problem and empower individuals to optimise their health.
Emma is a member of the International Society of Nutrigenetics/ Nutrigenomics (ISSN), Institute of Functional Medicine (IFM) and the British Association for Nutrition and Lifestyle Medicine (BANT) and is a regular speaker, presenter and participant at conferences on nutrition, genomics, genetics and epigenetics. She is also the author and co-presenter of Lifecode Gx® popular Nutrigenomics in Practice masterclasses.